Phare Bio and Collins Lab Awarded $27 Million in Funding to Develop Novel Antibiotics
Phare Bio, in collaboration with the Collins Lab at MIT and Wyss Institute, has been awarded up to $27 million in funding from ARPAH to enhance their generative artificial intelligence discovery platform and produce new classes of antibiotics. The funding will enable Phare Bio to add clinical precision to their AI platform, develop specific antibiotics,…